FIELD: medicine.
SUBSTANCE: cardiac arrest requires a cardiac perfusion of the Ringer's solution. And the solution is added with one of histidine containing peptides: homocarnosine concentrated 1-10 mM, or acetylcarnosine concentrated 10-25 mM, or anserine concentrated 10-25 mM, or acetylanserine concentrated 10-25 mM, or ophidine concentrated 0-25 mM.
EFFECT: method allows providing complete contractile cardiac function arrested by ischemia without intensifying myoglobin and adenosine loss, and increased left ventricle pressure.
2 tbl, 4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF NONCORONARY MYOCARDIUM NECROSIS MODELING | 2005 |
|
RU2366004C2 |
METHOD FOR PROTECTING HEART FROM ISCHEMIA UNDER EXPERIMENTAL CONDITIONS | 1996 |
|
RU2144825C1 |
ASN-BOKERIYA-BOLDYREV CARDIOPLEGIC SOLUTION | 2009 |
|
RU2413502C1 |
METHOD OF SIMULTANEOUS REGISTRATION OF NaDEPENDENT Ca FLOWS AND FUNCTIONAL STATE OF WHOLE ISOLATED HEART IN EXPERIMENT | 2009 |
|
RU2400825C1 |
METHOD FOR PRECONDITIONING MYOCARDIUM | 2006 |
|
RU2312691C1 |
METHOD FOR EVALUATING THE STATE OF MYOCARDIUM IN CARDIOSURGICAL INTERVENTIONS UNDER CONDITIONS OF CARDIOPLEGIC PROTECTION | 2017 |
|
RU2651364C1 |
"INFUSOL" CARDIOPLEGIC SOLUTION | 2002 |
|
RU2226093C1 |
METHOD FOR RESTORING HEART CONTRACTILITY AFTER CARDIOPLEGIA WITH CALCIUM ANTAGONISTS IN EXPERIMENT | 1996 |
|
RU2133612C1 |
MEASURING METHOD OF CARDIOMIOCYTE SWELLING OF WHOLE HEART, USED WHEN Ca IS REMOVED FROM EXTRACELLULAR MEDIUM DURING EXPERIMENT | 2006 |
|
RU2368956C2 |
METHOD FOR PRESERVING MYOCARDIUM ACCOMPANYING TRANSPLANTATION | 2013 |
|
RU2535036C1 |
Authors
Dates
2011-07-20—Published
2010-02-08—Filed